CIAS
ONC icon

Capital Investment Advisory Services’s BeOne Medicines Ltd ONC Stock Holding History

Capital Investment Advisory Services’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-200
Closed -$24K – 1285
2019
Q3 		$24K Hold
200
– – 0.01% 764
2019
Q2 		$26K Buy
+200
New +$25.4K 0.01% 719

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Inc
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

Capital Investment Advisory Services's ONC Position: Q4 2019 in Review

Capital Investment Advisory Services sold out of BeOne Medicines Ltd (ONC) in Q4 2019, closing a stake of 200 shares — an estimated $24K sold.

Capital Investment Advisory Services first reported a position in ONC in Q2 2019 and held it in 2 quarters. The position peaked at $26K in Q2 2019. 221 funds tracked by Wall St. Rank hold ONC as of Q4 2019.

  • Capital Investment Advisory Services reported no remaining BeOne Medicines Ltd position as of Q4 2019 after selling out during the quarter.
  • Capital Investment Advisory Services sold 200 BeOne Medicines Ltd shares in Q4 2019, an estimated $24K.
  • Capital Investment Advisory Services first reported a position in BeOne Medicines Ltd in Q2 2019 and held it in 2 quarters.
  • Capital Investment Advisory Services's BeOne Medicines Ltd position peaked at $26K in Q2 2019.
  • 221 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2019.

Based on Capital Investment Advisory Services's 13F filing for Q4 2019, filed 4 Feb 2020.